Takeda’s generic business is acquired by Sun Pharma subsidiary

Hannah Blake

pharmaphorum

Sun Pharmaceuticals has announced that its wholly-owned subsidiary, Caraco Pharmaceutical Laboratories, has entered into a definitive agreement with Takeda Pharmaceuticals to buy its URL Pharma generic business.

Japanese drug maker, Takeda, acquired URL Pharma, a formerly privately-held Philadelphia-based pharmaceutical company, in June 2012.

Upon completion of the purchase, the non-Colcrys (colchicine, USP) generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals.

&nbsp,

pharmaphorum-patient-nominations

&nbsp,

Related news:

Sun Pharma arm to buy Takeda’s US-based generics subsidiary URL Pharma (Economic Times)

Sun Pharma arm to buy generics business of US-based URL Pharma (Business Today)

Reference links:

Sun Pharma press release

&nbsp,

Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.